Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bright Minds Biosciences (DRUG) Share-based Compensation: 2020-2024

Historic Share-based Compensation for Bright Minds Biosciences (DRUG) over the last 5 years, with Sep 2024 value amounting to $617,402.

  • Bright Minds Biosciences' Share-based Compensation was N/A to $299,147 in Q3 2021 from the same period last year, while for Sep 2021 it was $700,787, marking a year-over-year change of. This contributed to the annual value of $617,402 for FY2024, which is 27.75% down from last year.
  • As of FY2024, Bright Minds Biosciences' Share-based Compensation stood at $617,402, which was down 27.75% from $854,523 recorded in FY2023.
  • Bright Minds Biosciences' 5-year Share-based Compensation high stood at $854,523 for FY2023, and its period low was $120,003 during FY2020.
  • Moreover, its 3-year median value for Share-based Compensation was $685,450 (2022), whereas its average is $719,125.
  • As far as peak fluctuations go, Bright Minds Biosciences' Share-based Compensation soared by 480.63% in 2021, and later dropped by 27.75% in 2024.
  • Bright Minds Biosciences' Share-based Compensation (Yearly) stood at $120,003 in 2020, then skyrocketed by 480.63% to $696,772 in 2021, then dropped by 1.63% to $685,450 in 2022, then climbed by 24.67% to $854,523 in 2023, then declined by 27.75% to $617,402 in 2024.